192,125 Shares in LivaNova PLC (NASDAQ:LIVN) Bought by Wellington Management Group LLP

Wellington Management Group LLP acquired a new position in LivaNova PLC (NASDAQ:LIVN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 192,125 shares of the company's stock, valued at approximately $8,897,000. Wellington Management Group LLP owned approximately 0.35% of LivaNova as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Russell Investments Group Ltd. grew its stake in LivaNova by 17.1% in the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock worth $70,000 after purchasing an additional 219 shares in the last quarter. Sterling Capital Management LLC boosted its position in LivaNova by 800.6% during the 4th quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock valued at $75,000 after acquiring an additional 1,441 shares in the last quarter. Vestcor Inc bought a new stake in LivaNova during the 4th quarter valued at $204,000. Optimize Financial Inc bought a new stake in LivaNova during the 4th quarter valued at $208,000. Finally, Corton Capital Inc. bought a new stake in LivaNova during the 4th quarter valued at $214,000. Institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

LIVN has been the topic of several recent research reports. Stifel Nicolaus dropped their target price on LivaNova from $72.00 to $60.00 and set a "buy" rating on the stock in a research report on Wednesday, February 26th. Wall Street Zen cut LivaNova from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 8th. Mizuho dropped their target price on LivaNova from $70.00 to $60.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 26th. Barclays decreased their price objective on LivaNova from $56.00 to $55.00 and set an "equal weight" rating for the company in a report on Thursday, May 8th. Finally, The Goldman Sachs Group decreased their price objective on LivaNova from $64.00 to $55.00 and set a "buy" rating for the company in a report on Monday, March 3rd. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, LivaNova has a consensus rating of "Buy" and an average target price of $59.29.

LivaNova Stock Performance

LIVN stock traded up $1.10 during midday trading on Friday, reaching $45.95. The stock had a trading volume of 932,281 shares, compared to its average volume of 649,297. The stock has a market cap of $2.51 billion, a PE ratio of 109.40 and a beta of 0.84. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37. The firm has a fifty day simple moving average of $39.56 and a two-hundred day simple moving average of $44.07. LivaNova PLC has a 52-week low of $32.48 and a 52-week high of $57.35.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.